(S (NP (NP (JJ Early) (NN detection)) (PP (IN of) (NP (NP (NN skin) (NN cancer)) (, ,) (ADVP (RB particularly)) (NP (NN melanoma)) (, ,)))) (VP (VBZ is) (ADJP (JJ crucial) (S (VP (TO to) (VP (VB enable) (NP (JJ advanced) (NN treatment))))))) (. .))
(S (PP (JJ Due) (TO to) (NP (NP (DT the) (JJ rapid) (NN growth)) (PP (IN in) (NP (NP (DT the) (NNS numbers)) (PP (IN of) (NP (NN skin) (NNS cancers))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (VBG growing) (NN need)) (PP (IN of) (NP (NP (JJ computerized) (NN analysis)) (PP (IN for) (NP (JJ skin) (NNS lesions))))))) (. .))
(S (NP (NP (DT The) (JJ state-of-the-art) (ADJP (JJ public) (JJ available)) (NNS datasets)) (PP (IN for) (NP (JJ skin) (NNS lesions)))) (VP (VBP are) (ADVP (RB often)) (VP (VBN accompanied) (PP (IN with) (NP (NP (ADJP (RB very) (JJ limited)) (NN amount)) (PP (IN of) (NP (NN segmentation) (NN ground) (NN truth) (VBG labeling))))) (SBAR (IN as) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ laborious) (CC and) (JJ expensive))))))) (. .))
(S (NP (DT The) (NN lesion) (JJ boundary) (NN segmentation)) (VP (VBZ is) (ADJP (JJ vital) (S (VP (TO to) (VP (VP (VB locate) (NP (DT the) (NN lesion)) (ADVP (RB accurately)) (PP (IN in) (NP (NN dermoscopic) (NNS images)))) (CC and) (NP (NP (NN lesion) (NN diagnosis)) (PP (IN of) (NP (JJ different) (JJ skin) (NN lesion) (NNS types))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (ADJP (RB fully) (VBN automated)) (JJ deep) (NN learning) (JJ ensemble) (NNS methods))) (PP (IN for) (NP (NP (JJ accurate) (NN lesion) (JJ boundary) (NN segmentation)) (PP (IN in) (NP (NN dermoscopic) (NNS images))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBD trained) (NP (DT the) (NNP Mask-RCNN) (CC and) (NNP DeepLabv3+) (NNS methods)) (PP (IN on) (NP (NNP ISIC-2017) (NN segmentation) (NN training) (VBN set)))) (CC and) (VP (VB evaluate) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (DT the) (JJ ensemble) (NNS networks))) (PP (IN on) (NP (NNP ISIC-2017) (VBG testing) (NN set)))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (ADJP (JJS best) (VBN proposed)) (JJ ensemble) (NN method)) (VP (VBD segmented) (NP (DT the) (JJ skin) (NNS lesions)) (PP (IN with) (NP (NP (NNP Jaccard) (NN index)) (PP (IN of) (NP (CD 79.58) (NN %))))) (PP (IN for) (NP (DT the) (JJ ISIC-2017) (NN testing) (NN set))))))) (. .))
(S (NP (DT The) (VBN proposed) (JJ ensemble) (NN method)) (VP (VBD outperformed) (NP (NP (NNP FrCN)) (, ,) (NP (NNP FCN)) (, ,) (NP (NNP U-Net)) (, ,) (CC and) (NP (NNP SegNet))) (PP (IN in) (NP (NNP Jaccard) (NNP Index))) (PP (IN by) (NP (NP (NP (CD 2.48) (NN %)) (, ,) (NP (CD 7.42) (NN %)) (, ,) (NP (CD 17.95) (NN %)) (, ,) (CC and) (NP (CD 9.96) (NN %))) (ADVP (RB respectively))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP (DT the) (VBN proposed) (JJ ensemble) (NN method)) (VP (VBD achieved) (NP (NP (NP (DT an) (NN accuracy)) (PP (IN of) (NP (NP (NP (CD 95.6) (NN %)) (PP (IN for) (NP (DT some) (JJ representative) (ADJP (RB clinically) (JJ benign)) (NNS cases)))) (, ,) (NP (NP (CD 90.78) (NN %)) (PP (IN for) (NP (DT the) (NN melanoma) (NNS cases)))) (, ,) (CC and) (NP (NP (CD 91.29) (NN %)) (PP (IN for) (NP (DT the) (JJ seborrheic) (NN keratosis) (NNS cases)))))))) (PP (IN on) (NP (NNP ISIC-2017) (VBG testing) (NN set))) (, ,) (S (VP (VBG exhibiting) (NP (NP (JJR better) (NN performance)) (PP (IN than) (NP (NP (NNP FrCN)) (, ,) (NP (NNP FCN)) (, ,) (NP (NNP U-Net)) (, ,) (CC and) (NP (NNP SegNet)))))))) (. .))
